Abiopharma

🔍 Lourd Bryan (Director)

Company: IAC Inc. (IAC)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 406 shares of Common Stock, par value $0.0001 at $40.03 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 197,950.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents share units accrued under the Non-Employee Director Deferred Compensation Plan as of the date of this report.
• F2: lncludes 151,777 share units accrued under the Non-Employee Director Deferred Compensation Plan as of the date of this report.